Bangalore based Strides Arcolab is likely to acquire the remaining 43 per
cent stake in its Australia based venture, Ascent Pharmahealth (APH). The
company already holds 57 per cent stake in APH.
However, no formal proposal has yet been put forward. Currently, the two
companies are holding discussion for the possible buy out.
Strides is likely to make a cash offer of Australian $35 million (approx Rs
145 crore). The acquisition is to be funded through company resources and debt.